Delivery Order SPE2DR25D6028-SPE2DR26FARAA
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,131.97 to AmerisourceBergen Drug Corp for 1,000 tablets of Lisinopril 40 mg, with an ultimate completion date of September 9, 2025. This non-set-aside contract employs firm fixed price terms and represents a direct fulfillment order under AmerisourceBergen's existing contract vehicle with DLA. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $47,100 to Amerisourcebergen Drug Corporation for 1,000 tablets of the pharmaceutical lisinopril. The order is to be fulfilled by Amerisourcebergen's Conshohocken, Pennsylvania facility by July 27, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense globally, this order for the blood pressure medication lisinopril is consistent with the Defense Logistics Agency's mission to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of 1,000 tablets of Lisinopril 10 mg, valued at $1,563.72. This is a firm fixed price delivery order with no set-aside designation, indicating the award was competitively bid. The contract is scheduled for ultimate completion on September 10, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Lisinopril is an ACE inhibitor...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,567,968,306 tablets of Lisinopril 40 mg, a hypertension medication, at a ceiling value of $2,584.98. The contract is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of April 21, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of 1,000 tablets of Lisinopril 40 mg, with a ceiling value of $2,041.70 and an ultimate completion date of September 16, 2025. This competitively awarded, non-set-aside delivery order uses firm fixed price pricing and is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,556,110,689 lisinopril 20 mg tablets in lots of 1,000. This $1,056.28 award is not associated with any set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on a larger $999,999,999.00 indefinite delivery contract with DLA to deliver pharmaceutical products and medical...
- The Defense Logistics Agency awarded a $24,220 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 1,000 tablets of 40mg lisinopril. The place of performance is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 18-19, 2023. No additional details were provided regarding the original solicitation or whether this delivery order was placed against an existing Government-Wide Acquisition Contract vehicle or set-aside...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,595.76 Firm Fixed Price Delivery Order contract is for the supply of 4,564,309,749 Lisinopril 40 mg tablets. The contract has an ultimate completion date of April 18, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- The Defense Logistics Agency awarded a $145,320 firm fixed price delivery order to AmerisourceBergen Drug Corporation for 1,000 tablets of 40mg lisinopril. The order is to be fulfilled by AmerisourceBergen's Corporate Office Division facility in Conshohocken, Pennsylvania by September 1, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations and works to support all military services and combatant commands worldwide. This delivery order for the...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $138,630 to Amerisourcebergen Drug Corporation to provide 1,000 tablets of the pharmaceutical lisinopril. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of one day, from August 24 to August 25, 2023. As a major distributor of pharmaceuticals and medical supplies to the Department of Defense, Amerisourcebergen will deliver the ordered quantity of the...
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FARAADelivery Order
The Defense Logistics Agency awarded a $1,248.47 delivery order to AmerisourceBergen Drug Corp for Lisinopril tablets, with an ultimate completion date of October 29, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which is valued at $999,999,999.00 and extends through December 2026. The delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor specializing in medical procurement for military and veteran healthcare systems. The company's DLA IDC serves as a comprehensive global pharmaceutical support vehicle enabling the delivery of a broad range of medications, vaccines, and medical supplies to support Department of Defense healthcare programs. This specific delivery order for Lisinopril tablets, a common antihypertensive medication, exemplifies the company's role in supplying routine pharmaceutical commodities to federal healthcare systems through its established prime vendor relationship with DLA Troop Support Medical.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 10/28/25 |